Welcome To MCB

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

4.7
(19)
121,592 views

*please excuse the google/sponsors ad , it helps us to cover website operational cost.



Publish News, Views, Consciences, Etc. 

mcb post icon

No SignUp, just

With Our Open Profile: WerMCBzen


Japan car output slumps on chip shortage
Japan car output slumps on chip shortage Global production at Japanese automakers including Honda slipped 4.5% in January from last ...
View Full Post
Medical Device CRO Market is estimated to be worth USD 15.7 billion in 2030
Advances in the medical device industry have led to a substantial increase in developmental complexity, clinical trial conduct, and stringency ...
View Full Post
Australia’s Qantas pushes back international flights
Australia's Qantas pushes back international flights Qantas Airways said it had pushed back its target for a widespread resumption of ...
View Full Post
U.S. report on Khashoggi murder expected soon: sources
U.S. report on Khashoggi murder expected soon: sources A declassified version of a U.S. intelligence report expected to be released ...
View Full Post
Medical Device Contract Manufacturing Market is estimated to be worth USD 126 Billion in 2030
Over the years outsourcing has become a popular trend among medical device developers, allowing such companies to leverage the expertise ...
View Full Post

Page Post Featured | Welcome To MCB

mcb post icon
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
13 views

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community.

Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

  • A detailed assessment of the current market landscape of ADCs.
  • Elaborate profiles of the clinical stage companies (shortlisted based on phase of development of the lead drug) and their respective product portfolios.
  • An analysis of the most commonly targeted therapeutic indications and details of ADC candidates being developed against them, highlighting key epidemiological facts about the diseases and currently available treatment options, other than ADCs.
  • A list of key opinion leaders (KOLs) within this domain.
  • An insightful competitiveness analysis of biological targets.
  • An analysis of the partnerships that have been established in the recent past.
  • An analysis of the investments made.
  • A study of the various grants that have been awarded to research institutes engaged in projects related to ADCs, between 2011 and 2019 (till April).
  • An elaborate discussion on the various strategies that can be adopted by the drug developers across key commercialization stages, namely prior to product launch, during / post launch.
  • An analysis of the key promotional strategies that have been adopted by the developers of marketed products.
  • An assessment of the various therapeutics that are being evaluated in combination with ADCs.
  • A review of the evolution of ADC conjugation technologies.
  • An overview of the studies conducted to better analyze non-clinical data and support first-in-human (FIH) dose selection in ADCs.
  • An elaborate discussion on various factors that form the basis for the pricing of ADC products.
  • A case study on manufacturing of ADCs, highlighting the key challenges, and a list of contract service providers that are involved in this domain.
  • A case study on companies offering companion diagnostics.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Type of payload

  • MMAE
  • DM4
  • Camptothecin
  • AM1
  • MMAF

Type of linker

  • VC
  • Sulfo-SPDB
  • SMCC
  • VA
  • Hydrazone linker
  • Others

Target Indications

  • Breast Cancer
  • Lymphoma
  • Leukemia
  • Urothelial cancer
  • Lung cancer
  • Ovaria cancer
  • Others

Target Antigen

  • CD30
  • HER2
  • CD22
  • CD33
  • Others
  • Small Molecule

Technology Providers

  • Seattle Genetics
  • ImmunoGen
  • StemCentRx
  • Immunomedics
  • Others

Key Geographies

  • North America
  • Europe
  • Asia Pacific

Transcripts of interviews held with the following senior level representatives of stakeholder companies:

  • Alan Burnett (Professor, School of Medicine, Cardiff University)
  • Aldo Braca (President and Chief Executive Officer) and Giorgio Salciarini (Technical Business Development Senior Manager, BSP Pharmaceuticals)
  • Anthony DeBoer (Director, Business Development, Synaffix)
  • Christian Bailly (Director of CDMO, Pierre Fabre)
  • Christian Rohlff, (Chief Executive Officer and Founder, Oxford BioTherapeutics)
  • Denis Angioletti (Chief Commercial Officer, Cerbios-Pharma)
  • John Burt (Chief Executive Officer, Abzena)
  • Jennifer L. Mitcham (Director, SMARTag ADCs and Bioconjugates) and Stacy McDonald (Group Product Manager, Catalent Pharma Solutions)
  • Laurent Ducry (Head of Bioconjugates Commercial Development, Lonza)
  • Mark Wright (Site Head, Piramal Healthcare)
  • Sasha Koniev (Chief Executive Officer & Co-Founder, Syndivia)
  • Tatsuya Okuzumi (Associate General Manager, Ajinomoto Bio-Pharma Services)
  • Toshimitsu Uenaka (Executive Director) and Takashi Owa (Chief Innovation Officer, Eisai)
  • Wouter Verhoeven (Chief Business Officer, NBE-Therapeutics)

Key companies covered in the report

  • Bristol Myers Squibb
  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Daiichi Sankyo
  • Pfizer
  • Roche / Genentech
  • Synthon
  • Bayer HealthCare
  • Biotest Pharmaceuticals

Request for PDF Sample of this Report:

https://www.rootsanalysis.com/reports/270/request-sample.html

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

Also Visit Our Latest Publication

Human Microbiome Market

In Silico / Computer-Aided Drug Discovery Services Market

Antibody Contract Manufacturing Market

Biopharma Contract Manufacturing MarketCell Therapy Manufacturing Market

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
11 views

Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.

To order this 250+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html

The over USD 5 billion (by 2030) financial opportunity within the endocannabinoid system targeted therapeutics market has been analyzed across the following segments:

  • Target Disease Indication
  • Cancer
  • Genetic Disorders
  • Neurological Indications
  • Others
  • Route of Administration
  • Oral
  • Inhalation
  • Key Geographies
  • North America
  • Europe

Asia-Pacific and the Rest of the World

The “Endocannabinoid System Targeted Therapeutics Market, 2020-2030report features the following companies, which we identified to be key players in this domain:

  • GW Pharmaceuticals
  • Corbus Pharmaceuticals
  • Tilray
  • Tetra Bio-Pharma
  • Botanix Pharmaceuticals
  • Kalytera Therapeutics
  • Therapix Biosciences
  • Echo Pharmaceuticals
  • Avicanna
  • GB Sciences

Table of Contents

1.         PREFACE

2.         EXECUTIVE SUMMARY

3.         INTRODUCTION

4.         MARKET LANDSCAPE: ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS

5.         COMPANY PROFILES

6.         ACADEMIC GRANTS ANALYSIS

7.         PARTNERSHIPS AND COLLABORATIONS

8.         MERGERS AND ACQUISITIONS

9.         DRUG DEVELOPMENT STRATEGY ANALYSIS

10.        MARKET FORECAST AND OPPORTUNITY ANALYSIS

11.        CONCLUDING REMARKS

12.        EXECUTIVE INSIGHTS

13.        APPENDIX 1: TABULATED DATA

14.        APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
9 views

Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030“ covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 250+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html

Key Market Insights

  • More than 65 industry players across the world are presently engaged in evaluating the clinical applications of over180 cannabinoid-derivatives that target the human endocannabinoid signaling system
  • The pipeline features a variety of marketed / clinical stage therapies, being investigated for a wide range of target disease indications and designed for administration via different routes
  • The geographical landscape of this industry is likely to evolve in the next few years as federal authorities legalize the use of medical cannabis across multiple countries
  • Despite the associated stigma, many organizations have extended financial support to aid research efforts in this domain; the focus is on understanding the clinical benefits of endocannabinoid signaling in different diseases
  • The growing interest in this field is also reflected by the 170+ partnerships that have been signed in the last five years, involving both international and indigenous stakeholders, across different geographical marketplaces
  • Presently, North American companies seem to be consolidating their presence indigenously, mostly through strategic acquisitions; key value drivers behind such deals include product and geographical expansion
  • Future market size, based on revenue generation potential of marketed and late stage therapies, is anticipated to be distributed across a variety of therapeutic areas, target receptors and key geographical regions

For more information, please visit “Endocannabinoid System Targeted Therapeutics Market, 2020-2030.“

Table of Contents

1.         PREFACE

1.1.       Scope of the Report

1.2.       Research Methodology

1.3.       Chapter Outlines

2.         EXECUTIVE SUMMARY

3.         INTRODUCTION

3.1.       Chapter Overview

3.2.       Neuropharmacology and Working Mechanism of the Endocannabinoid System

3.3.       Potential Therapeutic Applications of Cannabinoids

3.4.       Legal Aspects and Regulations

3.5.       Existing Challenges

3.6.       Future of Cannabinoid Therapies

4.         MARKET LANDSCAPE: ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS

4.1.       Chapter Overview

4.2.       Drugs Targeting Endocannabinoid System: Marketed and Development Pipeline

4.2.1.    Analysis by Phase of Development

4.2.2.    Analysis by Target Therapeutic Area

4.2.3.    Analysis by Route of Administration

4.2.4.    Analysis by Dosing Frequency

4.2.5.    Analysis by Target Receptor

4.2.6.    Grid Analysis: Distribution by Phase of Development, Target Therapeutic Area and Target Receptor

4.3.       Endocannabinoid System Targeted Therapeutics: List of Developers

4.3.1.    Analysis by Year of Establishment

4.3.2.    Analysis by Company Size and Geographical Location

4.4.       List of Cannabis Suppliers

5.         COMPANY PROFILES

5.1.       Chapter Overview

5.2.       GW Pharmaceuticals

5.2.1.    Company Overview

5.2.2.    Financial Information

5.2.3.    Endocannabinoid Targeting Therapeutics Portfolio

5.2.4.    Recent Developments and Future Outlook

5.3.       Corbus Pharmaceuticals

5.3.1.    Company Overview

5.3.2.    Endocannabinoid Targeting Therapeutics Portfolio

5.3.3.    Recent Developments and Future Outlook

5.4.       Tilray

5.4.1.    Company Overview

5.4.2.    Financial Information

5.4.3.    Endocannabinoid Targeting Therapeutics Portfolio

5.4.3.2.             Recent Developments and Future Outlook

5.5.       Pure Green

5.5.1.    Company Overview

5.5.2.    Endocannabinoid Targeting Therapeutics Portfolio

5.6.       Tetra Bio-Pharma

5.6.1.    Company Overview

5.6.2.    Endocannabinoid Targeting Therapeutics Portfolio

5.6.3.    Recent Developments and Future Outlook

5.7.       Botanix Pharmaceuticals

5.7.1.    Company Overview

5.7.2.    Endocannabinoid Targeting Therapeutics Portfolio

5.7.3.    Recent Developments and Future Outlook

5.8.       Kalytera Therapeutics

5.8.1.    Company Overview

5.8.2.    Endocannabinoid Targeting Therapeutics Portfolio

5.8.3.    Recent Developments and Future Outlook

5.9.       Therapix Biosciences

5.9.1.    Company Overview

5.9.2.    Endocannabinoid Targeting Therapeutics Portfolio

5.9.3.    Recent Developments and Future Outlook

5.10.     Zelira Therapeutics

5.10.1. Company Overview

5.10.2. Endocannabinoid Targeting Therapeutics Portfolio

5.10.3. Recent Developments and Future Outlook

5.11.     Avicanna

5.11.1. Company Overview

5.11.2. Financial Information

5.11.3. Endocannabinoid Targeting Therapeutics Portfolio

5.11.4. Recent Developments and Future Outlook

5.12.     GB Sciences

5.12.1. Company Overview

5.12.2. Financial Information

5.12.3. Endocannabinoid Targeting Therapeutics Portfolio

5.12.4. Recent Developments and Future Outlook

6.         ACADEMIC GRANTS ANALYSIS

6.1.       Chapter Overview

6.2.       Scope and Methodology

6.3.       Endocannabinoid System Targeted Therapeutics: List of Grants Awarded by National Institutes of Health (NIH)

6.3.1.    Analysis by Year of Grant Award

6.3.2.    Analysis by Amount Awarded

6.3.3.    Analysis by Administering Institute Center

6.3.4.    Analysis by Funding Institute Center

6.3.5.    Analysis by Support Period

6.3.6.    Analysis by Funding Institute Center and Support Period

6.3.7.    Analysis by Type of Grant Application

6.3.8.    Analysis by Purpose of Grant Award

6.3.9.    Analysis by Grant Mechanism

6.3.10. Word Cloud Analysis: Emerging Focus Areas

6.3.11. Analysis by Study Section Involved

6.3.12. Popular NIH Departments: Analysis by Number of Grants

6.3.13. Analysis by Types of Recipient Organizations

6.3.14. Prominent Program Officers: Analysis by Number of Grants

6.3.15. Popular Recipient Organizations: Analysis by Number of Grants

6.3.16. Regional Analysis of Recipient Organizations

7.         PARTNERSHIPS AND COLLABORATIONS

7.1.       Chapter Overview

7.2.       Partnership Models

7.3.       Endocannabinoid Targeted Therapeutics: List of Partnerships and Collaborations

7.3.1.    Analysis by Year of Partnership

7.3.2.    Analysis by Type of Partnership

7.3.3.    Analysis by Type of Partnership and Target Disease Indication

7.3.4.    Analysis by Year of Partnership and Type of Partner

7.3.5.    Most Active Players: Analysis by Number of Partnerships

7.3.6.    Regional Analysis

7.3.7.    Intercontinental and Intracontinental Agreements

8.         MERGERS AND ACQUISITIONS

8.1.       Chapter Overview

8.2.       Acquisition Models

8.3.       Endocannabinoid Targeted Therapeutics: Mergers and Acquisitions

8.3.1.    Cumulative Year-wise Trend

8.3.2.    Analysis by Type of Acquisition

8.3.3.    Year of Acquisitions and Deal Financials

8.3.4.    Geographical Analysis of Mergers and Acquisitions

8.3.5.    Ownership Change Matrix

8.3.6.    Most Active Players: Analysis by Number of Acquisitions

8.3.7.    Key Value Drivers

8.3.8.    Valuation Analysis: Acquisition Deal Multiples

9.         DRUG DEVELOPMENT STRATEGY ANALYSIS

9.1.       Chapter Overview

9.2.       Scope and Methodology

9.3.       Strategies Adopted by Late-Stage Drug Candidate Developers

10.        MARKET FORECAST AND OPPORTUNITY ANALYSIS

10.1.     Chapter Overview

10.2.     Forecast Methodology and Key Assumptions

10.3.     Global Endocannabinoid Targeted Therapeutics Market, 2020-2030

10.4.     Global Endocannabinoid Targeted Therapeutics Market: Individual Product Sales Forecasts

10.4.1. EPIDIOLEX® (GW Pharmaceuticals)

10.4.1.1. Target Patient Population

10.4.1.2. Sales Forecast

10.4.2. Sativex® (GW Pharmaceuticals)

10.4.2.1. Target Patient Population

10.4.2.2. Sales Forecast

10.4.3. PPP011 (Caumz)

10.4.3.1. Target Patient Population

10.4.3.2. Sales Forecast

10.4.4. Lenabasum

10.4.4.1. Target Patient Population

10.4.4.2. Sales Forecast

10.4.5.  CannEpil™

10.4.5.1. Target Patient Population

10.4.5.2.  Sales Forecast

10.5.     Global Endocannabinoid System Targeted Therapeutics Market: Focus on CB1, CB2 and TRPV1 Receptors

10.6.     Global Endocannabinoid System Targeted Therapeutics Market: Distribution by Region, 2020-2030

10.6.1. Endocannabinoid System Targeted Therapeutics Market in North America, 2020-2030

10.6.2. Endocannabinoid System Targeted Therapeutics Market in Europe, 2020-2030

10.6.3. Endocannabinoid System Targeted Therapeutics Market in Asia-Pacific, 2020-2030

10.6.4. Endocannabinoid System Targeted Therapeutics Market in Rest of the World, 2020-2030

10.7.     Global Endocannabinoid System Targeted Therapeutics Market: Distribution by Target Therapeutic Area, 2020-2030

10.7.1. Global Endocannabinoid System Targeted Therapeutics Market for Autoimmune Diseases, 2020-2030

10.7.2. Global Endocannabinoid System Targeted Therapeutics Market for Genetic Disorders, 2020-2030

10.7.3.  Global Endocannabinoid System Targeted Therapeutics Market for Neurological Disorders, 2020-2030

10.7.4. Global Endocannabinoid System Targeted Therapeutics Market for Pain Disorders, 2020-2030

10.8.     Global Endocannabinoid System Targeted Therapeutics Market: Distribution by Route of Administration

10.8.1.  Global Endocannabinoid System Targeted Therapeutics Market for Oral Therapies, 2020-2030

10.8.5.  Global Endocannabinoid System Targeted Therapeutics Market for Inhalation Therapies, 2020-2030

11.        CONCLUDING REMARKS

12.        EXECUTIVE INSIGHTS

12.1.     Chapter Overview

12.2      Zelira Therapeutics US           

12.2.1.  Company Snapshot

12.2.2.  Interview Transcript: Oludare Odumosu, Chief Executive Officer

12.3.     GB Sciences

12.3.1. Company Snapshot

12.3.2. Interview Transcript: Andrea Small-Howard, Chief Scientific Officer

12.4.     Tetra Bio-Pharma

12.4.1. Company Snapshot

12.4.2. Interview Transcript: Steeve Néron, Chief Operating Officer

12.5      Vireo Health    

12.5.1.  Company Snapshot

12.5.2.  Interview Transcript: Stephen Dahmer, Chief Medical Officer

13.        APPENDIX 1: TABULATED DATA

14.        APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
9 views

So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions

Roots Analysis is pleased to announce the publication of its recent study, titled, “Endocannabinoid System Targeted Therapeutics Market, 2020-2030.“

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of endocannabinoid system targeting drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:

  • A detailed assessment of the current market landscape of drug developers engaged in the development of endocannabinoid system targeted therapeutics.
  • Detailed profiles of developers of endocannabinoid system targeted therapeutics (shortlisted on the basis of the number of development programs).
  • An in-depth analysis of nearly 600 grants that have been awarded to research institutes engaged in endocannabinoid system targeted therapeutics projects.
  • An analysis of the partnerships that have been established in this domain, in the recent past.
  • A detailed analysis of the various mergers and acquisitions that have taken place in this domain, between 2016-2020
  • An insightful chessboard analysis highlighting the most popular drug development strategies / paths adopted by various drug developers in the domain of endocannabinoid system targeted therapeutics.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
  • Target Disease Indication
  • Cancer
  • Genetic Disorders
  • Neurological Indications
  • Others
  • Route of Administration
  • Oral
  • Inhalation
  • Key Geographies
  • North America
  • Europe
  • Asia-Pacific and the Rest of the World

Key companies covered in the report

  • GW Pharmaceuticals
  • Corbus Pharmaceuticals
  • Tilray
  • Tetra Bio-Pharma
  • Botanix Pharmaceuticals
  • Kalytera Therapeutics
  • Therapix Biosciences
  • Echo Pharmaceuticals
  • Avicanna
  • GB Sciences

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html

Other Recent Offerings 

  1. Neoantigen Targeted Therapies Market, 2019-2030
  2. Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics
  3. Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030
  4. Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030

Contact:
Gaurav Chaudhary
+1 (415) 800 3415

+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
11 views

So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions

London

Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings.

Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.

To order this 250+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html

Key Market Insights 

Over 175 drugs targeting the endocannabinoid system are currently under development

Most cannabinoid-based drug candidates are being developed to target the CB1 and CB2 receptors. Nearly 45% of such drugs are presently being investigated in clinical trials, while 50% are in the preclinical / discovery phase. Majority of these therapies (60%) are designed for oral administration.

More than 60 companies claim to develop endocannabinoid system targeted therapeutics

Post 2010, there has been a significant rise in the number of companies working in this domain; such companies represent 63% of the total number of players. Majority of the firms engaged in this domain (74%) are based in North America, followed by those headquartered in Asia-Pacific (16%), Europe (8%) and Latin America (2%).  

Partnership activity has grown at an annualized rate of 35%, between 2017 and 2019  

The maximum number of partnerships were observed in 2019 within this segment of the pharmaceutical industry. Majority of these agreements were reported to have been inked for research purposes (20%). In addition, more than 35 merger / acquisition deal were signed between 2016 and 2020; service / facility expansion emerged as the most prominent key value drivers for such agreements.

Close to 600 grants were awarded for supporting research on endocannabinoid system targeted therapeutics, since 2016

Almost 45% of the total amount awarded in the form of grants, was under the R01 (in support of health-related research and development based on the mission of the NIH) mechanism. Further, grants (394) worth USD 147 million were awarded to research projects related to endocannabinoid system.

At present, therapies intended for the treatment of neurological disorders represent the majority share of the overall endocannabinoid system targeted therapeutics market

Most of the therapies targeting neurological disorders are intended for the treatment of epilepsy. In addition to neurological disorders, therapies intended for autoimmune disorders, cancer and genetic disorders are likely to capture significant market opportunity in the foreseen future.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/316/request-sample.html

Key Questions Answered

  • Who are the leading industry players in this market?
  • What are the key clinical conditions addressed by endocannabinoid system targeted therapeutics?
  • What are the biological receptors targeted by cannabinoid-based therapies?
  • What are the factors that are likely to influence the evolution of this market?
  • What are the initiatives undertaken by start-ups and big pharma players engaged in this domain?
  • What kind of partnership models are commonly adopted by stakeholders in this industry?
  • How is the current and future market opportunity likely to be distributed across key market segments?

The over USD 5 billion (by 2030) financial opportunity within the endocannabinoid system targeted therapeutics market has been analyzed across the following segments:

  • Target Disease Indication
  • Cancer
  • Genetic Disorders
  • Neurological Indications
  • Others
  • Route of Administration
  • Oral
  • Inhalation
  • Key Geographies
  • North America
  • Europe
  • Asia-Pacific and the Rest of the World

The report features inputs from eminent industry stakeholders, according to whom, endocannabinoid system targeted therapeutics are considered as a promising alternative for the treatment of a diverse array of symptoms associated with a myriad of human diseases. The report includes detailed transcripts of the discussions held with industry experts.

The research includes detailed profiles of key players (listed below); each profile features an overview of the company, its financial information (if available), drug portfolio, recent developments and an informed future outlook.

  • GW Pharmaceuticals
  • Corbus Pharmaceuticals
  • Tilray
  • Tetra Bio-Pharma
  • Botanix Pharmaceuticals
  • Kalytera Therapeutics
  • Therapix Biosciences
  • Echo Pharmaceuticals
  • Avicanna
  • GB Sciences

For additional details, please visit 
https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html or email sales@rootsanalysis.com

You may also be interested in the following titles: 

  1. Neoantigen Targeted Therapies Market, 2019-2030
  2. Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics
  3. Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030
  4. Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030

Contact:
Gaurav Chaudhary
+1 (415) 800 3415

+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
9 views

To order this 180+ page report, please visit this AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030

Key Inclusions:

  • A review of the current market landscape of companies offering AR / VR based digital marketing services, featuring type of technology (AR, VR and MR), AR / VR specific services (video / content generation, website development, mobile application development and game development), additional digital marketing services (consulting, content marketing, customer relationship management, data analytics, marketing automation, product branding, quality assurance, SEO, SEM, social media marketing and training), information on the year of establishment, company size and location of headquarters. 
  • An insightful 2X2 representation, highlighting the competitiveness analysis of digital marketing companies, taking into consideration supplier power (based on company size) and service strength (based on strength of service portfolio) of the companies.
  • Elaborate profiles of prominent digital marketing companies, featuring a brief overview of the company, its financial information (if available), recent developments and an informed future outlook.
  • An analysis highlighting the potential strategic partners segregated on the basis of their likelihood of entering into collaboration with digital marketing companies. The analysis takes into consideration multiple relevant parameters, such as number of trials, therapeutic area, geographical footprint and company size.
  • An analysis of various AR / VR based digital marketing initiatives of big pharma players (shortlisted based on extent of activity in this domain), based on multiple parameters, such as the year of initiative, type of initiative, type of application area and type of solution. In addition, leading players and leading partners have been highlighted based on the number of initiatives.
  • A case study on recent use cases, wherein various digital marketing strategies have been adopted by pharmaceutical / healthcare players, highlighting different business needs of such players and key takeaways of the solutions provided by the digital marketing companies.

The USD 3.04 billion (by 2030) financial opportunity within the AR / VR based healthcare digital marketing service providers market has been analyzed across the following segments:

  • Type of Technology
  • AR Based Services
  • MR Based Services
  • VR Based Services
  • Type of product
  • Hardware
  • Software
  • End-User
  • Large Companies
  • Small and Mid-sized Companies
  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World 

To request sample pages, please visit this link

Key Questions Answered

  • Who are the leading players offering AR / VR based digital marketing services?
  • Which immersive technology, AR or VR, is likely to witness greater adoption in the immediate future?
  • How have big pharma players used AR / VR to create interactive and immersive experiences for their consumers?
  • Which companies are potential strategic partners for AR / VR based digital marketing service providers?
  • What are the factors that are likely to influence the evolution of this market?
  • How is the current and future opportunity likely to be distributed across key market segments?

You may also be interested in the following titles:

  1. Global Collaborative Robots (Cobots) Market, 2020-2030
    1. Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030
    1. Digital Twin Market: Global Opportunity and Trend Analysis, 2020-2035

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.Chaudhary@rootsanalysis.com

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
8 views

Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given the increasing demand for immersive technologies in the healthcare and pharma marketing, several stakeholders are expected to forge alliances with AR / VR service providers in the foreseen future. Owing to the rising interest of big pharma players in this domain, we expect an escalated industry-wide adoption of such technologies.

To order this 180+ page report, which features 45+ figures and 70+ tables, please visit AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030

The USD 3.04 billion (by 2030) financial opportunity within the AR / VR based healthcare digital marketing service providers market has been analyzed across the following segments:

  • Type of Technology
  • AR Based Services
  • MR Based Services
  • VR Based Services
  • Type of product
  • Hardware
  • Software
  • End-User
  • Large Companies
  • Small and Mid-sized Companies
  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World 

Key companies covered in the report

  • ARWorks
  • CG Life
  • CubeZoo
  • Impact XM
  • INVIVO Communications
  • Mirum
  • Pixacore
  • Random42
  • Quast Media
  • Tipping Point Media
  • vStream

Table of Contents

1.         Preface

2.         Executive Summary

3.         Introduction

4.         AR / VR Based Healthcare Digital Marketing Companies: Current Market Landscape

5.         Company Competitiveness Analysis

6.         Company Profiles

7.         Potential Strategic Partners

8.         Digital Marketing Related Initiatives of Big

Pharma Players

9.          Case Study

10.        Market Forecast

11.        Executive Insights

12.        Conclusion

13.        Appendix 1: Tabulated Data

14.        Appendix 2: List of Companies and Organisations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com 

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
9 views

Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 180+ page report, which features 45+ figures and 70+ tables, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html

Key Market Insights

  • Presently, more than 120 companies claim to offer AR / VR and affiliated digital marketing services to the global healthcare industry
  • In the last five years, several companies have entered this domain, offering app development and video / content generation services, through the use of both AR and VR technologies
  • Majority of the companies engaged in this field are based in developing regions; the market landscape is characterized by the presence of small and mid-sized firms
  • In order to achieve a competitive edge, companies are putting in significant efforts to expand their capabilities and enhance their respective service portfolios
  • Big pharma players have also invested significantly in various digital marketing and patient / physician training based initiatives through the use of AR / VR technologies
  • Given the growing popularity of AR / VR based marketing tools, various therapy developers are likely to forge alliances with AR / VR service providers in the foreseen future
  • Owing to the anticipated rate of adoption of AR / VR based technologies in the healthcare industry, the digital marketing service providers market is likely to grow at an annualized growth rate of ~30%, over the next decade

For more information, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html

Table of Contents

1.         PREFACE

1.1.       Scope of the Report

1.2.       Research Methodology

1.3.       Chapter Outlines

2.         EXECUTIVE SUMMARY

3.         INTRODUCTION

3.1.       Chapter Overview

3.2.       Key Challenges in Pharmaceutical Marketing

3.2.1.    Need for Product Differentiation

3.2.2.    Growing Demand for Patient Centric Healthcare

3.2.3.    Lack of Standard Performance Metrics

3.2.4.    Need for Scientific Communication

3.3.       Importance of Digital Marketing

3.4.       Popular Digital Marketing Strategies

3.4.1.    Social Media Marketing

3.4.2.    Content Marketing Strategy

3.4.3.    Marketing Automation

3.4.4.    Search Engine Optimization and Marketing

3.4.5.    Artificial Intelligence based Marketing

3.5.       Use of Augmented Reality and Virtual Reality (AR / VR) in

Pharmaceutical Digital Marketing

3.6.       Growth Constraints in AR / VR Industry

3.7.       Future Perspectives

4.         AR / VR BASED HEALTHCARE DIGITAL MARKETING COMPANIES: CURRENT MARKET LANDSCAPE

4.1.       Chapter Overview

4.2.       Digital Marketing in Pharmaceutical Industry: Overall Market                                            Landscape

4.2.1.    Analysis by Type of Technology

4.2.2.    Analysis by AR / VR based Services Offered

4.2.3.    Analysis by Type of Digital Marketing Services Offered

4.2.4.    Analysis by Secondary Marketing Services Offered

4.2.5.    Analysis by Year of Establishment

4.2.6.    Analysis by Company Size

4.2.7.    Analysis by Geographical Location

5.         COMPANY COMPETITIVENESS ANALYSIS

5.1.       Chapter Overview

5.2.       Methodology and Key Parameters

5.2.1.    Competitiveness Analysis: AR / VR based Digital Marketing

Service Providers based in North America

5.2.2.    Competitiveness Analysis: AR / VR based Digital Marketing

Service Providers based in Europe

5.2.3.    Competitiveness Analysis: AR / VR based Digital Marketing

Service Providers based in Asia-Pacific

6.         COMPANY PROFILES

6.1.       Chapter Overview

6.2.       ARworks

6.2.1.    Company Overview

6.2.2.    Recent Developments and Future Outlook

6.3.       CG Life

6.3.1.    Company Overview

6.3.2.    Recent Developments and Future Outlook

6.4.       CubeZoo

6.4.1.    Company Overview

6.4.2.    Recent Developments and Future Outlook

6. 5.      Impact XM

6. 5.1.   Company Overview

6. 5.2.   Recent Developments and Future Outlook

6.6.       INVIVO Communications

6.6.1.    Company overview

6.6.2.    Recent Developments and Future Outlook

6.7.       Mindgrub

6.7.1.    Company Overview

6.7.2.    Recent Developments and Future Outlook

6.8.       Mirum

6.8.1.    Company Overview

6.8.2.    Recent Developments and Future Outlook

6.9.       PIXACORE

6.9.1.    Company Overview

6.9.2.    Recent Developments and Future Outlook

6.10.     Quast Media

6.10.1.  Company Overview

6.10.2.  Recent Developments and Future Outlook

6.11.     Random42

6.11.1.  Company Overview

6.11.2.  Recent Developments and Future Outlook

6.12.     Tipping Point Media

6.12.1.  Company Overview

6.12.2.  Recent Developments and Future Outlook

6.13.     vStream

6.13.1.  Company Overview

6.13.2.  Recent Developments and Future Outlook

7.         POTENTIAL STRATEGIC PARTNERS

7.1.       Chapter Overview

7.2.       Scope and Methodology

7.3.       Potential Strategic Partners for Digital Marketing Companies

7.3.1.    Most Likely Partners

7.3.2.    Likely Partners

7.3.3.    Less Likely Partners

7.3.4.    Least Likely Partners

8.         DIGITAL MARKETING RELATED INITIATIVES OF BIG

PHARMA PLAYERS

8.1.       Chapter Overview

8.1.1.    Analysis by Year

8.1.2.    Analysis by Type of Initiative

8.1.3.    Analysis by Type of Application Area

8.1.4.    Analysis by Type of Solution

8.1.5.    Leading Players: Analysis by Number of Initiatives

8.1.6.    Leading Partners: Analysis by Number of Initiatives

9.          CASE STUDY

9.1.       Chapter Overview

9.2.       Narola Infotech for Zocular

9.2.1.    Narola Infotech

9.2.2.    Zocular

9.2.3.    Business Needs

9.2.4.    Objectives Achieved and Solutions Provided

9.3.       Viscira for Actelion

9.3.1.    Viscira

9.3.2.    Actelion

9.3.3.    Business Needs

9.3.4.    Objectives Achieved and Solutions Provided

9.4.       SoftCover VR for LifeLabs

9.4.1.    SoftCover VR

9.4.2.    LifeLabs

9.4.3.    Business Needs

9.4.4.    Objectives Achieved and Solutions Provided

9.5.       Virtual Reality Ireland for MISA

9.5.1.    Virtual Reality Ireland

9.5.2.    MISA

9.5.3.    Business Needs

9.5.4.    Objectives Achieved and Solutions Provided

9.6.       ViitorCloud for vCura

9.6.1.    ViitorCloud

9.6.2.    vCura

9.6.3.    Business Needs

9.6.4.    Objectives Achieved and Solutions Provided

9.7.       Kwebmaker for Lilavati Hospital

9.7.1.    Kwebmaker

9.7.2.    Lilavati Hospital

9.7.3.    Business Needs

9.7.4.    Objectives Achieved and Solutions Provided

9.8.       Intermind for My Health Meter

9.8.1.    Intermind

9.8.2.    My Health Meter

9.8.3.    Business Needs

9.8.4.    Objectives Achieved and Solutions Provided

9.9.       VR Vision for Providence Healthcare

9.9.1.    VR Vision

9.9.2.    Providence Healthcare

9.9.3.    Business Needs

9.9.4.    Objectives Achieved and Solutions Provided

9.10.     CitrusBits for Zoetis

9.10.1.  CitrusBits

9.10.2.  Zoetis

9.10.3.  Business Needs

9.10.4.  Objectives Achieved and Solutions Provided

10.        MARKET FORECAST

10.1.     Chapter Overview

10.2.     Forecast Methodology and Key Assumptions

10.3.     Overall AR / VR based Digital Marketing Opportunity in Healthcare

Industry, 2020-2030

10.4.     AR / VR based Digital Marketing Opportunity in Healthcare Industry:

Distribution by Type of Technology, 2020 and 2030

10.5.     AR / VR based Digital Marketing Opportunity in Healthcare Industry:

Distribution by Product, 2020 and 2030

10.6.     AR / VR based Digital Marketing Opportunity in Healthcare Industry:

Distribution by End-User, 2020 and 2030

10.7.     AR / VR based Digital Marketing Opportunity in Healthcare Industry:

Distribution by Key Geographical Regions, 2020 and 2030

10.7.1.  AR / VR based Digital Marketing Opportunity in Healthcare Industry

in North America, 2020-2030

10.7.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in North America: Distribution by Type of Technology, 2020 and 2030

10.7.1.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in North America: Share of AR based Services, 2020-2030

10.7.1.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in North America: Share of VR based Services, 2020-2030

10.7.1.1.3.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in North America: Share of Mixed Reality (MR) based Services, 2020-

2030

10.7.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in North America: Distribution by Type of Product, 2020 and 2030

10.7.1.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in North America: Share of Hardware Products, 2020-2030

10.7.1.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in North America: Share of Software Products, 2020-2030

10.7.2.  AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Europe, 2020-2030

10.7.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Europe: Distribution by Type of Technology, 2020 and 2030

10.7.2.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Europe: Share of AR based Services, 2020-2030

10.7.2.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Europe: Share of VR based Services, 2020-2030

10.7.2.1.3.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Europe: Share of MR based Services, 2020-2030

10.7.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Europe: Distribution by Type of Product, 2020 and 2030

10.7.2.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Europe: Share of Hardware Products, 2020-2030

10.7.2.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Europe: Share of Software Products, 2020-2030

10.7.3.  AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Asia-Pacific, 2020-2030

10.7.3.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Asia-Pacific: Distribution by Type of Technology, 2020 and 2030

10.7.3.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Asia-Pacific: Share of AR based Services, 2020-2030

10.7.3.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Asia-Pacific: Share of VR based Services, 2020-2030

10.7.3.1.3.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Asia-Pacific: Share of MR based Services, 2020-2030

10.7.3.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Asia-Pacific: Distribution by Type of Product, 2020 and 2030

10.7.3.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Asia-Pacific: Share of Hardware Products, 2020-2030

10.7.3.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Asia-Pacific: Share of Software Products, 2020-2030

10.7.1.  AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Rest of the World, 2020-2030

10.7.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Rest of the World: Distribution by Type of Technology, 2020 and

2030

10.7.1.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Rest of the World: Share of AR based Services, 2020-2030

10.7.1.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Rest of the World: Share of VR based Services, 2020-2030

10.7.1.1.3.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Rest of the World: Share of MR based Services, 2020-2030

10.7.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Rest of the World: Distribution by Type of Product, 2020 and 2030

10.7.1.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Rest of the World: Share of Hardware Products, 2020-2030

10.7.1.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry

in Rest of the World: Share of Software Products, 2020-2030

11.        EXECUTIVE INSIGHTS

11.1.     Chapter Overview

11.2.     Unanimity Information & Technology

11.2.1.  Interview Transcript: Pritam Sahu, Director, Unanimity Information &

Technology

11.3.     Kwebmaker

11.3.1. Interview Transcript: Dhananjay Arora, Founder and CEO,

Kwebmaker

12.        CONCLUSION

13.        APPENDIX 1: TABULATED DATA

14.        APPENDIX 2: LIST OF COMPANIES AND ORGANISATIONS

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
6 views

Over time, many pharma companies have begun incorporating augmented reality (AR) and virtual reality (VR) features, in order to offer an experiential and interactive dimension to their educational / marketing content

Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

The report features an extensive study of the current market landscape and future opportunities associated with the AR / VR based digital marketing industry in the healthcare domain. Amongst other elements, the report features:

  • A review of the current market landscape of companies offering AR / VR based digital marketing services. 
  • An insightful representation, highlighting the competitiveness analysis of digital marketing companies.
  • Elaborate profiles of prominent digital marketing companies, featuring a brief overview of the company, its financial information (if available), recent developments and an informed future outlook.
  • An analysis highlighting the potential strategic partners segregated on the basis of their likelihood of entering into collaboration with digital marketing companies.
  • An analysis of various AR / VR based digital marketing initiatives of big pharma players (shortlisted based on extent of activity in this domain), based on multiple parameters.
  • A case study on recent use cases, wherein various digital marketing strategies have been adopted by pharmaceutical / healthcare players.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
  • Type of Technology
  • AR Based Services
  • MR Based Services
  • VR Based Services
  • Type of product
  • Hardware
  • Software
  • End-User
  • Large Companies
  • Small and Mid-sized Companies
  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World 

Key companies covered in the report

  • ARWorks
  • CG Life
  • CubeZoo
  • Impact XM
  • INVIVO Communications
  • Mirum
  • Pixacore
  • Random42
  • Quast Media
  • Tipping Point Media
  • vStream

For more information, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html

Other recent offerings

You may also be interested in the following titles:

  1. Global Collaborative Robots (Cobots) Market, 2020-2030
    1. Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030
    1. Digital Twin Market: Global Opportunity and Trend Analysis, 2020-2035

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415 gaurav.chaudhary@rootsanalysis.com

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.

0
(0)
3 views

Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies

Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” report to its list of offerings.

Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given the increasing demand for immersive technologies in the healthcare and pharma marketing, several stakeholders are expected to forge alliances with AR / VR service providers in the foreseen future. Owing to the rising interest of big pharma players in this domain, we expect an escalated industry-wide adoption of such technologies.

To order this 180+ page report, which features 45+ figures and 70+ tables, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html

Key Market Insights

More than 125 companies claim to offer different AR / VR based digital marketing services to the healthcare and pharma industry.

The majority of players engaged in providing AR / VR based digital marketing services to the healthcare and pharmaceutical industry are small-sized companies (63%), followed by mid-sized (32%) and large players (5%). In addition, majority (38%) of the players were established during the period 2011-2015.

Several big pharma players have taken significant strides in in the field of AR / VR

These instances are either by collaborating with digital marketing service providers or through development of in-house capabilities. Majority (18%) of the instances were recorded in the year 2018.

More than 350 industry players have been identified as likely partners for AR / VR based digital marketing service providers

The potential strategic partners have been identified by evaluating more than 4,500 industry sponsored clinical trials (including phase I / II, phase II and phase II / III trials), and have been analyzed based on our proprietary scoring criteria.

Currently, a significant proportion (57%) of service revenues is generated from AR based digital marketing projects

In 2020, VR based projects are anticipated to contribute to 42% of the overall market share. It is worth mentioning that, in the foreseen future, service revenues generated through MR based technologies are anticipated to grow at a CAGR of 5% till 2030.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/323/request-sample.html

Key Questions Answered

  • Who are the leading players offering AR / VR based digital marketing services?
  • Which immersive technology, AR or VR, is likely to witness greater adoption in the immediate future?
  • How have big pharma players used AR / VR to create interactive and immersive experiences for their consumers?
  • Which companies are potential strategic partners for AR / VR based digital marketing service providers?
  • What are the factors that are likely to influence the evolution of this market?
  • How is the current and future opportunity likely to be distributed across key market segments?

The USD 3.04 billion (by 2030) financial opportunity within the AR / VR based healthcare digital marketing service providers market has been analyzed across the following segments:

  • Type of Technology
  • AR Based Services
  • MR Based Services
  • VR Based Services
  • Type of product
  • Hardware
  • Software
  • End-User
  • Large Companies
  • Small and Mid-sized Companies
  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World 

The report features inputs from eminent industry stakeholders, according to whom, a significant increase in adoption of AR / VR based digital marketing services is anticipated in pharmaceutical industry, in the foreseen future. The report includes detailed transcripts of the discussions held with the following experts:

The research includes detailed profiles of key players engaged in this domain; each profile features an overview of the company, recent developments and an informed future outlook.

  • ARWorks
  • CG Life
  • CubeZoo
  • Impact XM
  • INVIVO Communications
  • Mirum
  • Pixacore
  • Random42
  • Quast Media
  • Tipping Point Media
  • vStream

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html

You may also be interested in the following titles:

  1. Global Collaborative Robots (Cobots) Market, 2020-2030
  2. Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030
  3. Digital Twin Market: Global Opportunity and Trend Analysis, 2020-2035

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.Chaudhary@rootsanalysis.com

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.



mcb post icon
: ) Play with MCB Posts
as if those are your posts !

Power to Edit/Add/Improve any Post ! 

Visit  MCB Policy





Shop from Amazon:

  MCB Post

Add Your Any 

News, Views, Consciences, Etc.
as MCB Post

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community. Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), ...
View Full Post
Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop ...
View Full Post
Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030“ covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 250+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html Key Market Insights More than 65 industry ...
View Full Post
So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions Roots Analysis is pleased to announce the publication of its recent ...
View Full Post
So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions London Roots Analysis has announced the addition of “Endocannabinoid System ...
View Full Post
To order this 180+ page report, please visit this AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030 Key Inclusions: A review of the current market landscape of companies offering AR / VR based digital marketing services, featuring type of technology (AR, VR and MR), AR / VR ...
View Full Post
Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given the increasing demand for immersive ...
View Full Post
Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 180+ page report, which features 45+ figures and 70+ tables, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html Key Market ...
View Full Post
Over time, many pharma companies have begun incorporating augmented reality (AR) and virtual reality (VR) features, in order to offer an experiential and interactive dimension to their educational / marketing content Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” ...
View Full Post
Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” report to its list of offerings. Over ...
View Full Post

  MCB Page:

*We don’t allow unlimited uncensored , bad pages like other social media do, rather we believe in limited, well-made/monitored

Good Pages for Changes

Toward

Peace, Prosper and Profound Knowledge.

MCB-Trillioneom
Trillioneom The New Future will be reshaped in Trillion - ...
View Full Page
MCB-InfluenceOfInfinity
*Page is under construction, please check back later. Meanwhile below ...
View Full Page
MCB-BestOne
BestOne We've noticed for long google, youtube, i.e. whole internet ...
View Full Page
MCB-BiggerBolderBaking
YouTuber LiftUp We've noticed for long that New YouTubers or ...
View Full Page
MCB-YouTuberLiftUp-BiggerBolderBaking
YouTuber LiftUp We've noticed for long that New YouTubers or ...
View Full Page

How useful was this post?

Click on a star to rate it!


*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.

No Video(s) Found,
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Search Just What's on Your Mind ? . . .

*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.